Incyte News | finanzen.ch

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Historisch

Analysen

19.04.18	SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Incyte Corporation - INCY (PR Newswire)
06.04.18	Incyte, Merck Stop Phase 3 Study Of Epacadostat In Combination With KEYTRUDA (RTTNews)
28.03.18	Biotech Stocks Facing FDA Decision In April (RTTNews)
15.02.18	EARNINGS SUMMARY: Details of Incyte Corporation Q4 Earnings Report (RTTNews)
02.01.18	Vancouver Island 2018 Property Assessment Notices in the Mail (PR Newswire)
15.11.17	Incyte Starts Clinical Trial Of Ruxolitinib For Essential Thrombocythemia (RTTNews)
14.11.17	Le Cercle finance et placement du Québec reçoit Arjang Roshan, Président et chef de la direction chez 5N PLUS (PR Newswire)
06.11.17	Lilly, Incyte: Baricitinib Shows Greater Improvements In Pain Control In RA (RTTNews)
05.11.17	ACR/ARHP 2017: New Analysis Shows Rheumatoid Arthritis Patients Treated with Baricitinib Reported Greater Improvements in Pain Compared to Adalimumab or Placebo (PR Newswire)
31.10.17	Incyte Corporation Announces 2% Retreat In Q3 Earnings (RTTNews)
14.10.17	Indigenous groups, science community, marine industry, and government partners make progress in protecting endangered killer whale population (PR Newswire)
05.10.17	MDA Completes Acquisition of DigitalGlobe, Creates Industry Leader in Satellite Systems, Earth Imagery, Geospatial Solutions and Analytics (PR Newswire)
03.10.17	Arbor Pharmaceuticals, LLC & Debiopharm International annoncent la commercialisation de Triptodur™, formulation triptoreline 6 mois, pour le traitement des patients atteints de puberte precoce... (PR Newswire)
14.09.17	Lilly Announces New Safety And Efficacy Data From Phase 2 Study Of Baricitinib (RTTNews)
14.09.17	Baricitinib Meets Primary Endpoint in Phase 2 Study of Patients with Moderate-to-Severe Atopic Dermatitis (PR Newswire)
06.09.17	Landmark M&A Deals Continue to Shape Big Pharma (PR Newswire)
06.09.17	Landmark M&A Deals Continue to Shape Big Pharma (PR Newswire)
30.08.17	Lilly To Resubmit NDA For Baricitinib To FDA Before End Of January 2018 (RTTNews)
30.08.17	Lilly to File Baricitinib Resubmission to U.S. FDA before end of January 2018 (PR Newswire)
11.08.17	Technical Snapshots for These Biotech Stocks -- ImmunoGen, Incyte, Infinity Pharma, and Jazz Pharma (PR Newswire)
01.08.17	EARNINGS SUMMARY: Details of Incyte Corporation Q2 Earnings Report (RTTNews)
26.07.17	Positive Data IGNITEs TTPH, MDCO Makes A Good TANGO, Wait Continues For EGRX (RTTNews)
25.07.17	Eli Lilly & Incyte Issue Update On Resubmission Of NDA For Baricitinib (RTTNews)
25.07.17	Lilly and Incyte Provide Update on Baricitinib (PR Newswire)
21.07.17	AEZS Gets Down To Serious Work, APVO Surges, FDA Tentative Nod For MRK (RTTNews)
03.07.17	Eli Lilly Reports Japan Marketing Approval For Olumiant - Quick Facts (RTTNews)
03.07.17	Japan Ministry of Health, Labor and Welfare (MHLW) Grants Marketing Approval For Olumiant® (baricitinib) for the Treatment of Rheumatoid Arthritis (PR Newswire)
16.06.17	New Safety and Long-Term Efficacy Data from Baricitinib Clinical Trials in Patients with Moderate-to-Severe Rheumatoid Arthritis Presented at EULAR 2017 (PR Newswire)
14.06.17	Lilly to Present New Data on Olumiant® (baricitinib) in Rheumatoid Arthritis and Taltz® (ixekizumab) in Psoriatic Arthritis at the Annual European Congress of Rheumatology (EULAR 2017) (PR Newswire)
11.05.17	Technical Reports on Biotech Stocks -- Celsion, Incyte, ImmunoGen, and Catabasis Pharma (PR Newswire)
04.05.17	EARNINGS SUMMARY: Details of Incyte Corporation Q1 Earnings Report (RTTNews)
04.05.17	Incyte Posts Q1 Loss On Higher R&D Expenses; Jakafi Revenues Up 37% (RTTNews)
29.04.17	Lifshitz & Miller LLP Announces Investigation of Amyris, Inc., Commvault Systems, Inc., ICU Medical, Inc., Incyte Corporation, MOCON, Inc., Ocwen Financial Corporation and ThereapeuticsMD, Inc. (PR Newswire)
20.04.17	SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Incyte Corporation (INCY) (PR Newswire)
19.04.17	SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Incyte Corporation - INCY (PR Newswire)
18.04.17	Gainers & Losers Of Apr.17: CBLI, INFI, PBYI, OMED, INCY... (RTTNews)
17.04.17	Incyte Continues To Post Steep Loss After Initial Sell-Off (RTTNews)
17.04.17	FDA Says No To INCY, ZTS Snaps Up NVET, MDXG On The Move (RTTNews)
14.04.17	Eli Lilly And Incyte Say FDA Issues CRL For Baricitinib (RTTNews)
14.04.17	U.S. FDA Issues Complete Response Letter for Baricitinib (PR Newswire)
13.04.17	Company Spotlight: Incyte (RTTNews)
03.04.17	Setback For ACOR In Ampyra Suit, EARS Put On Notice, STDY On Steady Rise (RTTNews)
31.03.17	Incyte, Merck Give Further Details On Epacadostat - KEYTRUDA Clinical Program (RTTNews)
24.03.17	Biotech Stocks Facing FDA Decision In April (RTTNews)
03.03.17	How These Biotech Stocks are Faring? -- Geron, Incyte, Illumina, and Bellerophon Therapeutics (PR Newswire)
23.02.17	Incyte, CBOE Holdings, Regency Centers Set to Join S&P 500; Others to Join S&P MidCap 400 (PR Newswire)
15.02.17	Additional results from pivotal RA-BEAM study published in New England Journal of Medicine show baricitinib-treated patients demonstrated sustained improvement in rheumatoid arthritis compared to... (PR Newswire)
14.02.17	Incyte Corporation Bottom Line Falls 84% In Q4 (RTTNews)
13.02.17	European Commission Approves Once-Daily Olumiant Tablets for Treatment of Adults with Moderate-to-Severe Active Rheumatoid Arthritis (PR Newswire)
13.02.17	European Commission Approves Once-Daily Olumiant Tablets for Treatment of Adults with Moderate-to-Severe Active Rheumatoid Arthritis (PR Newswire)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

04.12.24		Gewinne in New York: S&P 500 legt mittags zu
19.11.24		Börse New York in Grün: S&P 500 zum Ende des Dienstagshandels im Aufwind
19.11.24		Optimismus in New York: Anleger lassen S&P 500 am Dienstagnachmittag steigen
19.11.24		Dienstagshandel in New York: S&P 500 mittags mit grünem Vorzeichen
19.11.24		Verluste in New York: S&P 500 startet im Minus
29.10.24		Börse New York in Grün: S&P 500 beendet die Sitzung im Plus
29.10.24		Börse New York: S&P 500 fester
29.10.24		Optimismus in New York: So bewegt sich der S&P 500 am Mittag

04.12.24

Gewinne in New York: S&P 500 legt mittags zu

19.11.24

Börse New York in Grün: S&P 500 zum Ende des Dienstagshandels im Aufwind

19.11.24

Optimismus in New York: Anleger lassen S&P 500 am Dienstagnachmittag steigen

19.11.24

Dienstagshandel in New York: S&P 500 mittags mit grünem Vorzeichen

19.11.24

Verluste in New York: S&P 500 startet im Minus

29.10.24

Börse New York in Grün: S&P 500 beendet die Sitzung im Plus

29.10.24

Börse New York: S&P 500 fester

29.10.24

Optimismus in New York: So bewegt sich der S&P 500 am Mittag

Portfolioname Watchlistname
Portfolio
Name
Typ
Valor / ISIN
Börse
Anzahl
Aktueller Kurs
Kurszeit
Kaufpreis
Kaufdatum
Kaufwert	CHF
	Hinzufügen Speichern

Lonza Grp	555.20	6.28 %	K V
CieFinRichemont	135.20	1.16 %	K V
Holcim	90.14	1.03 %	K V
UBS Group	28.56	0.92 %	K V
Logitech Intl	75.46	0.29 %	K V
Part Grp Hldg	1’294.50	-0.19 %	K V
Sika	231.20	-0.34 %	K V
Swiss Life Hldg	688.60	-0.46 %	K V
Roche Hldg G	254.50	-0.55 %	K V
Kuehne+Nagel Int	203.80	-3.37 %	K V

Nachrichten zu Incyte Corp.

Aktien Top/Flop

Incyte Peer Group Nachrichten

Meistgelesene Nachrichten